1. Screen Life Sciences

    0 Comments Leave a Comment

    1-9 of 9
    1. Mentioned In 9 Articles

    2. A Classification Tree Model with Optical Coherence Tomography Angiography Variables to Screen Early-Stage Diabetic Retinopathy in Diabetic Patients

      A Classification Tree Model with Optical Coherence Tomography Angiography Variables to Screen Early-Stage Diabetic Retinopathy in Diabetic Patients
      ...thms, these models solely focus on the systemic conditions of T2DM patients. A more straightforward method to screen DR is fundus imaging. Our present study is a combination of systemic conditions and fundus assessments....
      Read Full Article
    3. Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation

      Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation
      ...ted. Conclusion Imaging with OCT correlates well with IVUS for CAV detection. Combined angiography and OCT to screen for CAV within 1224 months of transplant predicts concurrent and future deterioration in graft function...
      Read Full Article
    4. Using Optical Coherence Tomography to Screen for Cognitive Impairment and Dementia

      Using Optical Coherence Tomography to Screen for Cognitive Impairment and Dementia
      Background: Screening for Alzheimer's disease and related disorders (ADRD) and mild cognitive impairment (MCI) could increase case identification, enhance clinical trial enrollment, and enable early intervention. MCI and ADRD screening would be most beneficial if detection measures reflect neurodegenerative changes. Optical coherence tomography (OCT) could be a marker of neurodegeneration (part of the amyloid-tau-neurodegeneration (ATN) framework). Objective: To determine whether OCT measurements can be used as a screening measure ...
      Read Full Article
    5. 1-9 of 9
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Screen Life Sciences

    Screen Life Sciences

    The SCREEN Group traces its history back to the Ishida Kyokuzan Printing Works, a lithographic printing shop founded in Kyoto, Japan in 1868. It offers numerous production systems, technologies and services that enjoy world leading market shares in the electronics and printing industries. The company also endeavors to create new businesses with the core technologies that have been cultivated over many years as its cornerstone. In the life science business, SCREEN has developed high-throughput, 3D cultured cell scanners and a system for the scanning and analysis of cellular morphologies, providing devices that are capable of rapidly measuring and analyzing the proliferation and morphological changes in cells without the use of test reagents